

Immunoprotein Diagnostic Testing Market Scope:
Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The global Immunoprotein Diagnostic Testing market is experiencing steady growth, driven by increasing prevalence of autoimmune diseases and infectious diseases. The market size is estimated to be valued at $6.3 billion in 2021 and is projected to reach $9.8 billion by 2026, with a CAGR of 9.2%. Request Sample Report
◍ Beckman Coulter
◍ DiaSorin
◍ F. Hoffmann-La Roche
◍ Siemens Healthineers
Competitive Landscape:
- Key players in the Immunoprotein Diagnostic Testing Market include Beckman Coulter, DiaSorin, F. HoffmannLa Roche, and Siemens Healthineers.
- These companies offer a wide range of immunoprotein diagnostic tests and solutions to healthcare providers globally.
Company Overview:
- Beckman Coulter, DiaSorin, F. Hoffmann-La Roche, and Siemens Healthineers are leaders in the Immunoprotein Diagnostic Testing Market, offering innovative products and technologies to meet the growing demand for accurate diagnostic testing.
- These companies play a crucial role in advancing the Immunoprotein Diagnostic Testing Market by developing new tests, expanding their product portfolios, and entering into strategic partnerships and collaborations.
- Sales Revenue (2020):
- Beckman Coulter: $7.8 billion
- DiaSorin: $1.6 billion
Request Sample Report
- F. Hoffmann-La Roche: $61.9 billion
- Siemens Healthineers: $15.3 billion
◍ Autoimmune Testing
◍ Infectious Disease Testing
◍ Allergy Testing
◍ Endocrine Testing
◍ Oncology Testing
◍ Toxicology Testing
◍ Others
◍ C-reactive Protein Diagnostic Test
◍ Complement System Protein Diagnostic Test
◍ Prealbumin Diagnostic Test
◍ Haptoglobin Diagnostic Test
◍ Immunoglobulin Diagnostic Test
◍ Free Light Chain Diagnostic Test
◍ Others
Request Sample Report
Request Sample Report
$ 7.98 Billion